Browse studies
Find your next paid study
14 recruiting studies matching your filters
Phase 2
Repurposing Celecoxib to Overcome Resistance to Immunotherapy in Advanced HCC (RECON Study)
This phase II trial tests how well the combination of celecoxib with durvalaumab and tremellimumab works in treating patients with hepatocellular cancer (liver…
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+1 more
Estimated
~$10 – $6,250
Emory UniversityNCT07174570
Phase 1
Phase I Study of GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Background: A new cancer treatment takes a person s own T cells, modifies them in a laboratory so they can better fight cancer cells, and then gives them back…
Hepatocellular CarcinomaHepatocellular CancerMetastatic Hepatocellular Carcinoma
Estimated
~$10 – $5,625
National Cancer Institute (NCI)NCT05003895